Seth Klarman: portfolio of Baupost Group
Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 12, 2016. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2016. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 7.3B USD
- Positions
- 38
- Share of the ten largest
- 74.8%
The ten largest positions Q2 2016
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2016
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| E M C Corp Mass | 21.1% | 56,961,725 | 1.5B USD | +9.9% increased | Q4 2015 3 quarters |
| Cheniere Energy Inc | 15.3% | 29,841,174 | 1.1B USD | unchanged | Q1 2014 10 quarters |
| Viasat Inc | 11.2% | 11,533,137 | 823.5M USD | unchanged | Q2 2013 or earlier 13 quarters |
| Allergan PLC | 6.3% | 2,001,978 | 462.6M USD | +16.3% increased | Q1 2016 2 quarters |
| Antero Res Corp | 5.1% | 14,505,881 | 376.9M USD | −32.5% reduced | Q3 2014 8 quarters |
| Olin Corp | 3.6% | 10,739,202 | 266.8M USD | unchanged | Q3 2015 4 quarters |
| Pbf Energy Inc | 3.5% | 10,641,175 | 253.0M USD | unchanged | Q3 2013 12 quarters |
| C Citigroup | 3.0% | 5,167,000 | 219.0M USD | new | Q2 2016 1 quarter |
| Twenty First Centy Fox Inc | 2.8% | 7,696,922 | 208.2M USD | unchanged | Q3 2015 4 quarters |
| PYPL PayPal | 2.8% | 5,664,087 | 206.8M USD | −19.8% reduced | Q3 2015 4 quarters |
| Twenty First Centy Fox Inc | 2.7% | 7,278,100 | 198.3M USD | unchanged | Q3 2015 4 quarters |
| Innoviva Inc | 2.5% | 17,610,091 | 185.4M USD | −11.1% reduced | Q1 2016 2 quarters |
| Keryx Biopharmaceuticals Inc | 2.3% | 25,791,678 | 170.7M USD | unchanged | Q1 2014 10 quarters |
| Theravance Biopharma Inc | 2.3% | 7,350,991 | 166.8M USD | +13.1% increased | Q2 2014 9 quarters |
| Vmware Inc | 1.8% | 2,252,694 | 128.9M USD | unchanged | Q1 2016 2 quarters |
| Atara Biotherapeutics Inc | 1.6% | 5,359,632 | 120.6M USD | unchanged | Q4 2014 7 quarters |
| Veritiv Corp | 1.6% | 3,044,385 | 114.4M USD | unchanged | Q3 2014 8 quarters |
| Forward Pharma A/S | 1.3% | 5,367,300 | 97.5M USD | unchanged | Q4 2014 7 quarters |
| Liberty Interactive Corp | 1.2% | 2,469,533 | 91.5M USD | new | Q2 2016 1 quarter |
| Chipmos Tech Bermuda Ltd | 0.9% | 3,751,853 | 67.9M USD | unchanged | Q2 2013 or earlier 13 quarters |
| Klx Inc | 0.8% | 2,000,000 | 62.0M USD | unchanged | Q1 2015 6 quarters |
| Novagold Res Inc | 0.8% | 9,500,000 | 58.1M USD | −36.7% reduced | Q2 2013 or earlier 13 quarters |
| Avis Budget Group | 0.8% | 1,787,227 | 57.6M USD | new | Q2 2016 1 quarter |
| Sunedison Semiconductor Ltd | 0.7% | 8,372,979 | 49.7M USD | unchanged | Q2 2014 9 quarters |
| American Intl Group Inc | 0.7% | 2,550,917 | 47.7M USD | +20.1% increased | Q2 2013 or earlier 13 quarters |
| Liberty Media Corp Delaware | 0.6% | 2,994,010 | 43.9M USD | new | Q2 2016 1 quarter |
| Silver Run Acquisition Corp | 0.5% | 3,750,000 | 36.8M USD | new | Q2 2016 1 quarter |
| Paratek Pharmaceuticals Inc | 0.4% | 2,044,498 | 28.4M USD | +32.4% increased | Q4 2014 7 quarters |
| Cascadian Therapeutics Inc | 0.3% | 25,000,000 | 23.6M USD | new | Q2 2016 1 quarter |
| Credit Accep Corp Mich | 0.3% | 100,000 | 18.5M USD | new | Q2 2016 1 quarter |
| RUN Sunrun | 0.2% | 2,848,082 | 16.9M USD | unchanged | Q3 2015 4 quarters |
| Och Ziff Cap Mgmt Group | 0.2% | 3,373,891 | 12.8M USD | new | Q2 2016 1 quarter |
| Liberty Media Corp Delaware | 0.2% | 800,000 | 12.0M USD | new | Q2 2016 1 quarter |
| Kindred Biosciences Inc | 0.1% | 3,013,848 | 10.7M USD | unchanged | Q4 2013 11 quarters |
| Orexigen Therapeutics Inc | 0.1% | 22,268,399 | 9.6M USD | unchanged | Q3 2015 4 quarters |
| Citigroup Inc | < 0.1% | 102,553,207 | 6.0M USD | unchanged | Q2 2013 or earlier 13 quarters |
| Novacopper Inc | < 0.1% | 10,600,758 | 5.3M USD | unchanged | Q2 2013 or earlier 13 quarters |
| Silver Run Acquisition Corp | < 0.1% | 1,250,000 | 1.4M USD | new | Q2 2016 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 1 position in convertible bonds and bonds worth 38.9M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Theravance Inc principal 48.2M USD 38.9M USD
Breakdown by sector
- Financials 5.8%
- Industrials 0.2%
- not in our coverage 94.0%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors